Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:56 AM
Ignite Modification Date:
2025-12-25 @ 2:56 AM
NCT ID:
NCT00257933
Eligibility Criteria:
Inclusion Criteria:
* Physician-diagnosed asthma with at least two previous visits to ED or primary care provider for asthma care
* Clinical decision by ED attending physician to admit to Acute Care Unit (ACU) after standardized initial ED treatment
Exclusion Criteria:
* Clinical decision to begin continuous intravenous beta-agonist infusion
* Clinical decision to begin intravenous methylprednisolone therapy
* Clinical decision to admit to the Pediatric Intensive Care Unit
* Other concurrent disease such as sickle cell disease, cystic fibrosis, or cardiac disease
* Any contraindication to corticosteroid administration
* Any systemic corticosteroid treatment within two weeks of presenting to the ED
* Potential subjects will be excluded if informed consent is not obtained
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
2 Years
Maximum Age:
18 Years
Study:
NCT00257933
Study Brief:
Protocol Section:
NCT00257933